Sugi Predict

Sugi Predict / Compounds / SCHEMBL1373008

SCHEMBL1373008

SCHEMBL1373008

CCOC(=O)n1nc2c(c1NC(=O)c1ccccc1N)CN(S(=O)(=O)c1cc(F)cc(F)c1)C2(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CREBBP Q92793 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ IGF1R P08069 1/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ HDAC1 Q13547 2/20 0.32
▸ TSHR P16473 1/20 0.32
▸ LMNA P02545 5/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ABCB1 P08183 1/20 0.31
▸ ABCG2 Q9UNQ0 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1372652 0.92 USP2 (0.34) SMN1; SMN2MAPTHSD17B10KMT2AUSP2
SCHEMBL1372178 0.89 ALDH1A1 (0.33) MAPTKMT2AUSP2POLBIGF1R
SCHEMBL1375199 0.89 NTRK1 (0.33) USP2POLBIGF1RHDAC1HDAC2
SCHEMBL1373849 0.88 ALDH1A1 (0.40) SMN1; SMN2MAPTKMT2ANPSR1POLB
SCHEMBL1886723 0.88 SMN1; SMN2 (0.36) SMN1; SMN2MAPTHSD17B10KMT2ANPSR1
SCHEMBL1372986 0.86 ALK (0.43) IGF1RHDAC2
SCHEMBL1371564 0.86 SMN1; SMN2 (0.37) SMN1; SMN2MAPTHSD17B10KMT2ANPSR1
Hydrochloric Acid SCHEMBL1372982 0.86 ALK (0.42) IGF1RHDAC2
Hydrochloric Acid SCHEMBL4278059 0.86 ALK (0.42) IGF1RHDAC2
SCHEMBL1371041 0.86 NTRK1 (0.37) SMN1; SMN2MAPTHSD17B10KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461193-B2 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-06-11 — — US disclosed
US-20110288088-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.I. (IT) 2011-11-24 — — US disclosed
US-7968583-B2 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-06-28 — — US disclosed
US-20090163503-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-25 — — US disclosed
EP-1963326-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-09-03 — — EP disclosed
WO-2007068637-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163503-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K5, MAP3K19, MAP3K3 SMN1; SMN2 3697/4885MAPT 2209/4885HSD17B10 3405/4885
US-20110288088-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K5, MAP3K19, MAP3K3 SMN1; SMN2 3697/4885MAPT 2209/4885HSD17B10 3405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.